AF
VTAK icon

Allworth Financial’s Catheter Precision VTAK Stock Holding History

Allworth Financial’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$303 Buy
+300
New +$508 ﹤0.01% 4845

Other funds holding VTAK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PUI
Purpose Unlimited Inc Toronto $2.42B AUM
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Allworth Financial's VTAK Position: Q1 2026 in Review

Allworth Financial opened a new position in Catheter Precision (VTAK) in Q1 2026: 300 shares worth $303. The stake represents ﹤0.01% of the portfolio and ranks #4845 among its holdings.

12 funds tracked by Wall St. Rank hold VTAK as of Q1 2026.

  • Allworth Financial held 300 shares of Catheter Precision worth $303 as of Q1 2026.
  • Catheter Precision was a new Allworth Financial position in Q1 2026.
  • Catheter Precision made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4845 holding.
  • 12 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.